Agilent Completes $4.5 Billion Stock Buyback Ahead of Schedule

Jun 22, 2006

NEW YORK, June 22 (GenomeWeb News) - Agilent Technologies has completed its $4.5 billion stock repurchase program ahead of schedule, the company said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

IBM, Broad to Map Human Microbiome on World Community Grid
Autism Appears Overrepresented in Certain Mitochondrial Haplogroups
iCubate Receives CE Mark for Platform, Bloodstream Infection Assay
Caprion Collaborating with FNIH on Alzheimer's Biomarkers
Jennifer Doudna, Feng Zhang Awarded NHGRI Grants for CRISPR-Based Research
BRCA1/2 LOH Testing May Offer Treatment Response Clues in Some Cancer Cases

The Scan

Spiders and Scorpions, Oh My!

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

Keep It Secret

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Page Joins Chronic Disease Startup

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

This Week in Cell

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.

Main menu